1
|
Iacone A, Dragani A, Angelini A, Accorsi P, Fioritoni G, D'Antonio D, Torlontano G. Early Hematopoietic Reconstitution after Autologous Transplantation with Blood-Derived Stem Cells in a Patient with Advanced Lymphoma. Int J Artif Organs 2018. [DOI: 10.1177/039139888901200609] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
A 30-year-old man with advanced non-Hodgkin lymphoma underwent repeated leukaphereses for harvesting blood-derived hemopoietic stem cells. Collection was started 8-10 days after the end of L-VAMP therapy (3 cycles). Nine procedures were performed and a total of 65.4× 109 mononuclear cells (0.87× 109/Kg) were collected, processed, cryopreserved and stored in liquid nitrogen. The yields of CFU-GM, BFU-E and CFU-GEMM were respectively 964× 104 (12.4× 104/Kg), 249× 104 (3.2× 104/Kg) and 798× 104 (10.4× 104). The patient received a myeloablative regimen consisting of fractionated total body irradiation (1200 cGy) and cyclophosphamide (120 mg/kg) followed by infusion of his own thawed cells. Early trilineage hematopoietic recovery was first observed on day +8; 1× 109/l WBC were reached on day + 11, 0.5× 109/l PMN on day + 13 and 50× 109/l platelets on day + 11. Course was uneventful and the patient was discharged from hospital on day + 21. Eight months after transplant the patient is in continuous unmaintained complete remission with normal blood cell counts. This reports suggests that complete and sustained engraftment can be achieved with peripheral stem cells recruited after “soft” chemotherapy.
Collapse
Affiliation(s)
- A. Iacone
- Chair of Hematology, University of Chieti, Civil Hospital of Pescara - Italy
- Division of Hematology and Blood Bank, Civil Hospital of Pescara - Italy
| | - A. Dragani
- Chair of Hematology, University of Chieti, Civil Hospital of Pescara - Italy
- Division of Hematology and Blood Bank, Civil Hospital of Pescara - Italy
| | - A. Angelini
- Chair of Hematology, University of Chieti, Civil Hospital of Pescara - Italy
- Division of Hematology and Blood Bank, Civil Hospital of Pescara - Italy
| | - P. Accorsi
- Chair of Hematology, University of Chieti, Civil Hospital of Pescara - Italy
- Division of Hematology and Blood Bank, Civil Hospital of Pescara - Italy
| | - G. Fioritoni
- Chair of Hematology, University of Chieti, Civil Hospital of Pescara - Italy
- Division of Hematology and Blood Bank, Civil Hospital of Pescara - Italy
| | - D. D'Antonio
- Chair of Hematology, University of Chieti, Civil Hospital of Pescara - Italy
- Division of Hematology and Blood Bank, Civil Hospital of Pescara - Italy
| | - G. Torlontano
- Chair of Hematology, University of Chieti, Civil Hospital of Pescara - Italy
- Division of Hematology and Blood Bank, Civil Hospital of Pescara - Italy
| |
Collapse
|
2
|
Iacone A, Pierelli L, Quaglietta A, Nicolucci A, Menichella G, Di Bartolomeo P, De Laurenzi A, Fioritoni G, Indovina A, Leone G, Majolino I, Montuoro A, Di Marzio A, Torlontano G. Survival after PBSC Transplantation and Comparison of Engraftment Speed with Autologous and Allogeneic Marrow Transplantation: Results of a Multicenter Study. Int J Artif Organs 2018. [DOI: 10.1177/039139889301605s09] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
We have analyzed the results of a multicenter study on peripheral blood stem cell transplantation (PBSCT) performed on 55 patients suffering from various neoplastic diseases. After myeloablative therapy, they received a mediam of 6.8x108/kg MNC and 11.4x104/kg CFU-GM harvested by a median of 9 apheresis after mobilization with chemotherapy alone. As of date, 34 of the 55 patients are alive and 28 of them are in continuous complete remission after a follow-up of 30 months. The probability of survival was related to the disease status at transplant, CR/PR vs. PD (p= 0.0001) and the bone marrow involvement, BM-vs. BM+ (P=0.009). Furthermore, a comparative study on speed of engraftment and clinical management was conducted on the 55 PBSCT patients as well as on 41 autoBMT and 52 alloBMT patients. Days to reach WBC> 1.0x109/L, PMN> 0.5x109/L and PLT> 50x109/L was 12/14/33 for PBSCT, 17/20/23 for ABMT and 15/16.5/18 for BMT, respectively. Days with fever >38° C, systemic antibiotic therapy and length of hospitalization was 3/12/36 for PBSCT, 5/18.5/42 for ABMT and 9/25/46 for BMT respectively.
Collapse
Affiliation(s)
- A. Iacone
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | - L. Pierelli
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - A.M. Quaglietta
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | - A. Nicolucci
- Mario Negri Sud Institute, S. Maria Imbaro, Chieti
| | - G. Menichella
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - P. Di Bartolomeo
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | | | - G. Fioritoni
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | - A. Indovina
- Division of Hematology, “V. Cervello” Hospital, Palermo
| | - G. Leone
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - I. Majolino
- Division of Hematology, “V. Cervello” Hospital, Palermo
| | - A. Montuoro
- Hematology Division, San Camillo Hospital, Roma
| | - A. Di Marzio
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - G. Torlontano
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
- Chair of Hematology, University of Chieti, Chieti
- IRCCS, San Giovanni Rotondo, Foggia - Italy
| |
Collapse
|
3
|
Tribalto M, Papa G, Coppetelli U, Adorno G, Caravita T, Dentamaro T, Rainone A, Avvisati G, La Verde G, Leone G, Menichella G, Martelli M, Tabilio A, Iacone A, Fioritoni G, Majolino I, Scimè R, Mandelli F. Treatment of Multiple Myeloma with Autologous Blood Stem Cell Transplantation. Preliminary Results of an Italian Multicentric Pilot Study. Int J Artif Organs 2018. [DOI: 10.1177/039139889301605s10] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Starting from May, 1991, 35 untreated myeloma patients entered a multicentric pilot study to evaluate the feasibility of a program of PBSC transplantation for previously untreated myeloma patients. The schedule was as follows: 2 cycles of VAD followed by CY, 7 g/mq + G-CSF (Granulokine, Roche) for 14 days, to increase and collect PBSC. The subsequent conditioning regimen was Melphalan + Busulfan followed by G-CSF. As maintenance R alpha-2 IFN was given, until relapse. The median follow-up is 14 months (4-22). On April 1993, 34 patients received at least 2 cycles of VAD, 27 were submitted to PBSC collection, 22 received conditioning regimen plus PBSC and 16 of them are in the maintenance treatment with IFN. Considering 28 patients for an intention to treat evaluation (35 -7 in treatment), responding patients are 71% with 46% who achieved CR. White cells and platelets raised to > 1000/mmc and >50,000/mmc after a median period of 10 and 13 days, from CY, and 11 and 14 days from transplant, respectively. Two patients relapsed, 2 others died while in PR because of CMV epatitis and candida pneumonia. The median number of CD34+ cells and CFU-GM was 24.75 x 106/kg b.w. and 28.1 x 104/kg b.w. respectively. In conclusion this treatment seems to be feasible and with low toxicity, but a longer follow-up is needed to evaluate the progression free survival of the high proportion of responding patients that we observed.
Collapse
Affiliation(s)
- M. Tribalto
- Department of Hematology, “Tor Vergata” University, Roma
| | - G. Papa
- Department of Hematology, “Tor Vergata” University, Roma
| | - U. Coppetelli
- Department of Hematology, “Tor Vergata” University, Roma
| | - G. Adorno
- Department of Hematology, “Tor Vergata” University, Roma
| | - T. Caravita
- Department of Hematology, “Tor Vergata” University, Roma
| | - T. Dentamaro
- Department of Hematology, “Tor Vergata” University, Roma
| | - A. Rainone
- Department of Hematology, “Tor Vergata” University, Roma
| | - G. Avvisati
- Department of Hematology, “La Sapienza” University, Roma
| | - G. La Verde
- Department of Hematology, “La Sapienza” University, Roma
| | - G. Leone
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - G. Menichella
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - M. Martelli
- Division of Hematology, University of Perugia, Perugia
| | - A. Tabilio
- Division of Hematology, University of Perugia, Perugia
| | - A. Iacone
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | - G. Fioritoni
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | - I. Majolino
- Division of Hematology, “V. Cervello” Hospital, Palermo, Italy
| | - R. Scimè
- Division of Hematology, “V. Cervello” Hospital, Palermo, Italy
| | - F. Mandelli
- Department of Hematology, “La Sapienza” University, Roma
| |
Collapse
|
4
|
Dragarli A, lacone A, Angelini A, D'Antonio D, Accorsi P, Fioritoni G, Geraci L, Berardi A, Quaglietta A, Di Bartolomeo P, Antonucci A, Torlontano G. Seven-day Storage of Single Donor Platelets in Polyolefin Bags: Clinical, Biochemical, Morphological and Microbiological Evaluation. Int J Artif Organs 2018. [DOI: 10.1177/039139888801100112] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
We compared the in vitro and in vivo function of fresh and stored platelet concentrates (PCs) collected by an automated continuous-flow blood cell separator (CS 3000 Fenwal) in a closed-system apheresis kit in order to evaluate the possibility of extending the storage time to seven days with the polyolefin container (PL-732). The initial 220 ml platelet volume (5.14 ± 1.23 x 1011) was divided into two parts. Half was transfused and the other half was stored for 7 days. All cultured units were negative for bacterial contamination. Mean counts for fresh and stored platelets were respectively 2.34 ± 0.59 and 2.17 ± 0.50 x 1011/100 ml of PCs (mean recovery 88.7 ± 11.9%). The pO2 levels were maintained during storage (179.9 ± 30.5 mmHg) but pCO2, pH, LDH, osmolality, glucose consumption, bicarbonates, ATP, and osmotic stress values changed significantly after 7 days storage. From a clinical point of view, in 14 patients receiving a total of 38 PC transfusions no statistically significant change in corrected post-transfusional levels was observed between fresh and stored PC. Biochemical and morphological data and clinical results suggest that PCs collected with CS-3000 blood cell separator in a closed system and stored for 7 days in polyolefin bags (PL-732) can be satisfactorily employed in clinical practice.
Collapse
Affiliation(s)
- A. Dragarli
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - A. lacone
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - A. Angelini
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - D. D'Antonio
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - P. Accorsi
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - G. Fioritoni
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - L. Geraci
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - A. Berardi
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - A. Quaglietta
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - P. Di Bartolomeo
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - A. Antonucci
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| | - G. Torlontano
- Institutes of Hematology and Istology Division of Hematology and Blood Bank Pescara - Italy
| |
Collapse
|
5
|
Hengeveld M, Suciu S, Chelgoum Y, Marie JP, Muus P, Lefrère F, Mandelli F, Pane F, Amadori S, Fioritoni G, Labar B, Baron F, Cermak J, Bourhis JH, Storti G, Fazi P, Hagemeijer A, Vignetti M, Willemze R, de Witte T. High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT. Bone Marrow Transplant 2014; 50:341-7. [PMID: 25402418 DOI: 10.1038/bmt.2014.262] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2013] [Revised: 09/18/2014] [Accepted: 09/19/2014] [Indexed: 11/09/2022]
Abstract
The faster hematopoietic recovery after autologous peripheral blood SCT (APBSCT) in patients with AML may be offset by an increased relapse risk as compared with autologous BMT (ABMT). The EORTC and GIMEMA Leukemia Groups conducted a trial (AML-10) in which they compared, as second randomization, APBSCT and ABMT in first CR patients without an HLA compatible donor. A total of 292 patients were randomized. The 5-year DFS rate was 41% in the APBSCT arm and 46% in the ABMT arm with a hazard ratio (HR) of 1.17; 95% confidence interval=0.85-1.59; P=0.34. The 5-year cumulative relapse incidence was 56% vs 49% (P=0.26), and the 5-year OS 50% and 55% (P=0.6) in the APBSCT and ABMT groups, respectively. APBSCT was associated with significantly faster recovery of neutrophils and platelets, shorter duration of hospitalization, reduced need of transfusion packed RBC and less days of intravenous antibiotics. In both treatment groups, higher numbers of mobilized CD34+ cells were associated with a significantly higher relapse risk irrespective of the treatment given after the mobilization. Randomization between APBSCT and ABMT did not result in significantly different outcomes in terms of DFS, OS and relapse incidence.
Collapse
Affiliation(s)
- M Hengeveld
- Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
| | - S Suciu
- EORTC Headquarters, Brussels, Belgium
| | | | | | - P Muus
- Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
| | - F Lefrère
- Necker-Institut Curie, Paris, France
| | | | - F Pane
- Federico II University, Napoli, Italy
| | - S Amadori
- Tor Vergata University Hospital, Roma, Italy
| | | | - B Labar
- University Hospital Rebro, Zagreb, Croatia
| | - F Baron
- CHU Sart-Tilman, Liège, Belgium
| | - J Cermak
- Institute Hematology, Prague, Czech Republic
| | - J-H Bourhis
- Gustave Roussy Comprehensive Cancer Center, Villejuif, France
| | - G Storti
- A.O.R.N. San Giuseppe Moscati, Avelino, Italy
| | - P Fazi
- GIMEMA Data Center, Roma, Italy
| | - A Hagemeijer
- Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium
| | | | - R Willemze
- Leiden University Medical Center, Leiden, The Netherlands
| | - T de Witte
- Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
| |
Collapse
|
6
|
Voso MT, Fabiani E, Piciocchi A, Matteucci C, Brandimarte L, Finelli C, Pogliani E, Angelucci E, Fioritoni G, Musto P, Greco M, Criscuolo M, Fianchi L, Vignetti M, Santini V, Hohaus S, Mecucci C, Leone G. Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine. Leukemia 2011; 25:1910-3. [PMID: 21760590 DOI: 10.1038/leu.2011.170] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
7
|
Majolino I, Quaglietta AM, Iacone A, Scime R, Fioritoni G, De Rosa L, Pierelli L, Indovina A, Spadano A, De Laurenzi A. Autologous Blood Stem Cell Transplantation in Malignant Lymphomas: An Italian Cooperative Study. Leuk Lymphoma 2009; 7 Suppl:11-6. [PMID: 1362918 DOI: 10.3109/10428199209061557] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Twenty-three patients with malignant lymphoma, (7 Hodgkin's, and 16 non-Hodgkin's) in different phases of disease were autografted in 4 Italian Haematology institutions using only chemotherapy-mobilized blood stem cells (BSC) collected by apheresis. Clinical and laboratory data were analysed centrally and showed mean collection yields of 8.1 x 10(8) kg mononuclear cells (MNC) (SE 0.5; range 2.6-13.8) and 24.1 x 10(4) kg CFU-GM (SE 7.4; range 1.4-162.9). The mean times required to attain 0.5 x 10(9)/l neutrophils and 50 x 10(9)/l platelets after marrow-ablative high-dose chemo+radiotherapy and BSC reinfusion were 14.9 days (SE 1.5; range 7-38) and 18.6 days (SE 2.6; range 6-49) respectively. The incidence of early deaths was < 5% and the requirement for support with blood product transfusion was moderate. The progression free survival (PFS) is > 50% at 3 years with a median follow-up of 17.3 months. Results were significantly better for patients autografted in remission. These results suggest that autologous blood stem cell transplantation (ABSCT) may be proposed for the primary treatment of poor prognosis malignant lymphomas. However, ABSCT needs to be compared with autologous bone marrow transplantation (ABMT) followed by infusion of growth factors to accelerate recovery.
Collapse
Affiliation(s)
- I Majolino
- Divisione di Ematologia, Unita Trapianti, Ospedale V. Cervello, Palermo, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Pulini S, D'Amico E, Basilico R, Mereu M, Bacci F, Spadano A, Fioritoni G. Portal venous thrombosis in a young patient with idiopathic myelofibrosis and intrahepatic extramedullary hematopoiesis: a difficult diagnosis, prognosis and management. Leukemia 2007; 21:2373-5. [PMID: 17581614 DOI: 10.1038/sj.leu.2404789] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
9
|
Pulini S, Di Lorenzo R, Morelli A, D'Amico E, Mereu M, Basilico R, Fioritoni G. PO-72 A rare case of portal vein thrombosis complicating juvenile idiopathic myelofibrosis with intrahepatic haematopoiesis. Thromb Res 2007. [DOI: 10.1016/s0049-3848(07)70225-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
10
|
Lessiani G, Falco A, Dragani A, Fioritoni G, La Barba G, Fioritoni F, Michetti N, Recchiuti A, Davi G. Mo-P2:192 Polycythemia vera and endothelial dysfunction: Role of CD40 ligand. ATHEROSCLEROSIS SUPP 2006. [DOI: 10.1016/s1567-5688(06)80327-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
11
|
Magarelli N, Guglielmi G, Savastano M, Toro V, Sborgia M, Fioritoni G, Mattei PA, Steinbach L, Bonomo L. Superficial inflammatory and primary neoplastic lymphadenopathy: diagnostic accuracy of power-doppler sonography. Eur J Radiol 2004; 52:257-63. [PMID: 15544903 DOI: 10.1016/j.ejrad.2003.10.020] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2003] [Revised: 10/18/2003] [Accepted: 10/20/2003] [Indexed: 11/23/2022]
Abstract
OBJECTIVE To evaluate the sensitivity, specificity and diagnostic accuracy of a cut-off of the resistive index of 0.5 for the differentiation between inflammatory and neoplastic primary lymphadenopathies. SUBJECTS AND METHODS We measured the resistive index of superficial enlarged lymph nodes in a total of 50 patients (29 males and 21 females; age range 12-72 years, mean age 41.6 year) using an ATL 5000 HDI. A resistive index greater than or equal to 0.5 indicated an inflammatory lymph node and a resistive index <0.5 was consistent with neoplastic primary lymphadenopathies. The gold standard was either surgical biopsy or lymph-node reduction seen with ultrasound examination after antibiotic therapy. RESULTS The sensitivity of the resistive index for distinguishing inflammatory from neoplastic lymphadenopathy was 84.6%, the specificity 100% and the diagnostic accuracy 95.7% (P < 0.001, statistically significant). CONCLUSION The results of this study indicate that power-Doppler using a resistive index cut-off of 0.5 was a valid technique for distinguishing between inflammatory and primary neoplastic lymph nodes in patients with superficial lymphadenopathies.
Collapse
Affiliation(s)
- N Magarelli
- Department of Radiology, University G. d'Annunzio, 667100 Chieti, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
12
|
D'Antonio D, Staniscia T, Piccolomini R, Fioritoni G, Rotolo S, Parruti G, Di Bonaventura G, Manna A, Savini V, Fiorilli MP, Di Giovanni P, Francione A, Schioppa F, Romano F. Addition of Teicoplanin or Vancomycin for the Treatment of Documented Bacteremia due to Gram-Positive Cocci in Neutropenic Patients with Hematological Malignancies: Microbiological, Clinical and Economic Evaluation. Chemotherapy 2004; 50:81-7. [PMID: 15211082 DOI: 10.1159/000077807] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2002] [Accepted: 07/25/2003] [Indexed: 11/19/2022]
Abstract
A prospective, randomized, double-blind trial was conducted on 124 febrile patients with hematological malignancies to compare teicoplanin with vancomycin as an addition to the initial empiric amikacin-ceftazidime regimen after documented bacteremia due to gram-positive cocci. At enrollment, patients in both groups were comparable with respect to age, sex, underlying hematologic disorders and duration of neutropenia. Rates of therapeutic success were 55/63 (87.3%) in the teicoplanin group and 56/61 (91.8%) in the vancomycin group (p = 0.560). The mean duration of treatment was similar, being 12.2 and 11.4 days, respectively (p = 0.216). Patients treated with teicoplanin remained febrile for slightly longer than those treated with vancomycin (4.9 vs. 4.0 days) (p = 0.013). Thirteen patients experienced an adverse drug reaction, but without any significant difference in the two arms. Isolated staphylococci showed a progressive and significant decrease in susceptibility to both glycopeptides during the 8 study years. The economic analysis performed showed that the addition of vancomycin is cost-saving.
Collapse
Affiliation(s)
- D D'Antonio
- Dipartimento di Ematologia e Medicina Trasfusionale, Ospedale Spirito Santo, Pescara, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Todeschini G, Secchi S, Morra E, Vitolo U, Orlandi E, Pasini F, Gallo E, Ambrosetti A, Tecchio C, Tarella C, Gabbas A, Gallamini A, Gargantini L, Pizzuti M, Fioritoni G, Gottin L, Rossi G, Lazzarino M, Menestrina F, Paulli M, Palestro M, Cabras MG, Di Vito F, Pizzolo G. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer 2004; 90:372-6. [PMID: 14735179 PMCID: PMC2409547 DOI: 10.1038/sj.bjc.6601460] [Citation(s) in RCA: 114] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
The optimal treatment of primary mediastinal large B-cell lymphoma (PMLBCL) is still undefined. In the absence of randomised studies, we retrospectively analysed: (a) the effectiveness of two chemotherapy regimens (CHOP vs MACOP-B/VACOP-B) in complete remission (CR) achievement and event-free survival (EFS) and (b) the role of mediastinal involved-field radiotherapy (IF-RT) as consolidation. From 1982 to 1999, 138 consecutive patients affected by PMLBCL were treated in 13 Italian institutions with CHOP (43) or MACOP-B/VACOP-B (95). The two groups of patients were similar as regard to age, gender, presence of bulky mediastinal mass, pleural effusion, stage and international prognostic indexes category of risk. Overall, 75.5% of patients in CR received IF-RT as consolidation. Complete remission was 51.1% in the CHOP group and 80% in MACOP-B/VACOP-B (P<0.001). Relapse occurred in 22.7% of CHOP- and in 9.2% of MACOP-B/VACOP-B-treated patients (n.s.). Event-free patients were 39.5% in CHOP and 75.7% in the MACOP-B/VACOP-B group (P<0.001). The addition of IF-RT as consolidation improved the outcome, irrespectively of the type of chemotherapy (P=0.04). At a multivariate analysis, achievement of CR (P<0.0001) and type of CT (MACOP-B/VACOP-B) retained the significance for OS (P=0.008) and EFS (P=0.03). In our experience, MACOP-B/VACOP-B appears to positively influence OS and EFS in patients affected by PMLBCL, as compared to CHOP. Consolidation IF-RT on mediastinum further improves the outcome of CR patients.
Collapse
Affiliation(s)
- G Todeschini
- Department of Hematology, Verona University, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Mandelli F, Latagliata R, Avvisati G, Fazi P, Rodeghiero F, Leoni F, Gobbi M, Nobile F, Gallo E, Fanin R, Amadori S, Vignetti M, Fioritoni G, Ferrara F, Peta A, Giustolisi R, Broccia G, Petti MC, Lo-Coco F. Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols. Leukemia 2003; 17:1085-90. [PMID: 12764372 DOI: 10.1038/sj.leu.2402932] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
In all, 134 elderly patients (median age 66 years, range 60-75 years) with newly diagnosed acute promyelocytic leukemia (APL) were enrolled in two successive protocols of the Italian multicenter group GIMEMA. All patients received an identical induction with all-trans retinoic acid and idarubicin; 116 (86%) entered complete remission (CR), two (2%) were resistant and 16 (12%) died during induction. After CR, 106 patients received further therapy whereas 10 did not, because of refusal (n=5) or toxicity (n=5). Consolidation consisted of three chemotherapy courses in the AIDA protocol (AIDA, 67 patients) or, since 1997, of an amended protocol including only the first cycle (amended AIDA, aAIDA, 39 patients). In the AIDA group, 43 patients (64%) completed consolidation, while seven (11%) and 17 (25%) patients were withdrawn after first and second courses, respectively; nine patients (13%) died in CR and 12 (18%) relapsed. In the aAIDA group, all patients received the assigned treatment; two patients (5%) died in CR and six (15%) relapsed. In the AIDA and aAIDA series, the 3-year overall and discase-free survival rates were 81 and 83% (P=NS), 73 and 72% (P=NS), respectively. We highlight here the frequency and severity of complications linked to intensive chemotherapy in this clinical setting and suggest that, in APL of the elderly, less intensive postremission therapy allows significant reduction of severe treatment-related toxicity and may be equally effective.
Collapse
Affiliation(s)
- F Mandelli
- Department of Cellular Biotechnology and Hematology, University of Rome La Sapienza, Via Benevento 6, Rome 00161, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Accorsi P, Dell'Isola M, Bonfini T, Giancola R, Spadano A, Fioritoni G, Iacone A. Large volume leukapheresis with AMICUS cell separator in peripheral blood stem cell autologous transplant. Transfus Apher Sci 2001; 24:79-83. [PMID: 11515615 DOI: 10.1016/s0955-3886(00)00130-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- P Accorsi
- Department of Transfusion Medicine, Centro Studi E. Jucci Ciancarelli, Ospedale Civile, Pescara, Italy
| | | | | | | | | | | | | |
Collapse
|
16
|
Sanz MA, Lo Coco F, Martín G, Avvisati G, Rayón C, Barbui T, Díaz-Mediavilla J, Fioritoni G, González JD, Liso V, Esteve J, Ferrara F, Bolufer P, Bernasconi C, Gonzalez M, Rodeghiero F, Colomer D, Petti MC, Ribera JM, Mandelli F. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 2000; 96:1247-53. [PMID: 10942364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023] Open
Abstract
Preliminary independent reports of the Italian GIMEMA and the Spanish PETHEMA trials for newly diagnosed acute promyelocytic leukemia (APL) indicated a similarly high antileukemic efficacy in terms of complete remission and disease-free survival rates. To better investigate these studies and the prognostic factors influencing relapse risk, this study analyzed the updated results of 217 patients with PML/RAR alpha-positive APL enrolled in GIMEMA (n = 108) and PETHEMA (n = 109). All patients received identical induction (AIDA schedule) and maintenance. For consolidation, GIMEMA patients received 3 courses including idarubicin/cytarabine, mitoxantrone/etoposide, and idarubicin/cytarabine/thioguanine, whereas PETHEMA patients received the same drugs and dose schedule of idarubicin and mitoxantrone with the omission of nonintercalating agents. Depending on whether molecular relapses were classified as censored or uncensored events, the 3-year Kaplan-Meier estimates of relapse-free survival (RFS) for the combined series were 90 +/- 2% and 86 +/- 2%, respectively. Minor differences observed between the 2 patient cohorts were negligible. Multivariate regression analysis of RFS showed that initial leukocyte (WBC) and platelet counts were the only variables with independent prognostic value. The resulting predictive model for RFS demonstrated its capability of segregating patients into low-risk (WBC count </= 10 x 10(9)/L, platelet count > 40 x 10(9)/L), intermediate-risk (WBC count </= 10 x 10(9)/L, platelets </= 40 x 10(9)/L), and high-risk (WBC count > 10 x 10(9)/L) groups, with distinctive RFS curves (P <.0001). The conclusions are that omission of nonanthracycline drugs from the AIDA regimen is not associated with reduced antileukemic efficacy and a simple predictive model may be used for risk-adapted therapy in this disease. (Blood. 2000;96:1247-1253)
Collapse
Affiliation(s)
- M A Sanz
- Hospital Universitario La Fe, Valencia, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Bonfini T, Accorsi P, Giancola R, Liberatore E, Dell'Isola M, Di Bartolomeo P, Fioritoni G, Iacone A. Kinetic of intraprocedure CD34+ cell release during pbsc collection in healthy donors. Exp Hematol 2000. [DOI: 10.1016/s0301-472x(00)00450-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
18
|
Tribalto M, Amadori S, Cudillo L, Caravita T, Del Poeta G, Meloni G, Avvisati G, Petrucci MT, Pulsoni A, Leone G, Sica S, Martelli M, Tabilio A, Fioritoni G, Majolino I, Mandelli F. Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study. Haematologica 2000; 85:52-8. [PMID: 10629592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023] Open
Abstract
BACKGROUND AND OBJECTIVE The outcome of patients with multiple myeloma (MM) has not changed markedly since the introduction of melphalan and prednisone. In recent years several studies have investigated the role of intensive therapy followed by infusion of autologous peripheral blood stem cells (PBSC) together with the administration of hematopoietic growth factors. In this study we evaluated the feasibility and efficacy of a PBSC transplantation program for patients with de novo MM in a multicenter setting. DESIGN AND METHODS In a non-randomized controlled trial 52 patients with de novo MM from 6 Italian centers underwent a three phase treatment strategy including 3 cycles of VAD-like chemotherapy for initial debulking, followed by high-dose cyclophosphamide (HD-CY) and collection of PBSC, that were transplanted after a conditioning regimen with melphalan plus busulfan. Maintenance treatment was a conventional dose of interferon, given until relapse. Actuarial survival and response duration curves were plotted according to Kaplan and Meier's method; the groups were compared using the log rank test. Response rates were compared by the c(2) test; multivariate analysis was performed according to the stepwise regression model. RESULTS Overall 39/52 (75%) of patients responded, with a complete remission (CR) rate of 31%. After a median follow-up of 55 months, median duration of event-free survival (EFS) and overall survival (OS) are 21 and 57 months, with 24% and 48% probabilities of being event-free and alive after 6 years, respectively. Among the group of 39 responders, CR was significantly associated with prolonged response and survival (2 deaths and 6 relapses/16 patients) as compared with PR (11 deaths and 15 relapses/23 patients), and remained the only significant variable also in a multivariate analysis. Myelosuppression did not protract beyond one week in transplanted patients; extra-hematologic toxicity was very low. INTERPRETATION AND CONCLUSIONS This multicenter study confirms the feasibility of an aggressive approach to de novo MM patients. Additional confirmation is given of the increased rate of CR, and the significant prolonged survival observed in complete responders. In this experience the association melphalan plus busulfan was shown to be effective, at least as part of conditioning regimens, in the transplant strategy.
Collapse
Affiliation(s)
- M Tribalto
- Divisione di Ematologia, Ospedale S. Eugenio, piazzale dell'Umanesimo, 00144 Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Cimino G, Elia L, Rapanotti MC, Sprovieri T, Mancini M, Cuneo A, Mecucci C, Fioritoni G, Carotenuto M, Morra E, Liso V, Annino L, Saglio G, De Rossi G, Foà R, Mandelli F. A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia. Blood 2000; 95:96-101. [PMID: 10607691] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/14/2023] Open
Abstract
Twenty-five patients (22 adults and 3 infants) with ALL1/AF4-positive acute lymphoblastic leukemia (ALL) were prospectively monitored by reverse transcriptase-polymerase chain reaction (RT-PCR) between January 1992 and July 1999. After high-dose induction and consolidation chemotherapy without bone marrow transplantation, all patients had a complete hematologic remission. Using nested RT-PCR (sensitivity 10(-4)), we observed conversion to PCR negativity in 11 (44%) of the patients. Thirteen of the 14 patients who did not have a molecular remission had a relapse at a median time of 4 months (range, 1 - 20 months). Of the 11 patients who had a conversion to PCR negativity, 5 reconverted to PCR positivity within 1 to 14 months. These 5 patients all progressed to hematologic relapse after 2, 3, 4, 4, and 7 months, respectively. Of the remaining 6 patients, 4 are in persistent hematologic and molecular remission at 12, 14, 88, and 96 months, whereas 2 are early in their follow-up. Actuarial probabilities of relapse and overall survival were 100% and 0% at 14 and 24 months and 67% and 43% at 96 and 100 months, respectively, in patients who had persistent RT-PCR positivity and in those who had a molecular remission. For both relapse and survival, the differences observed between the two groups were significant (P =.003 and P <.005, respectively). This study, which represents the first prospective analysis of residual-disease monitoring carried out in a substantial series of patients with t(4;11)-positive ALL, emphasizes the clinical relevance of RT-PCR-based methods to monitor minimal residual disease in this leukemia subset. (Blood. 2000;95:96-101)
Collapse
Affiliation(s)
- G Cimino
- Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood 1997; 90:1014-21. [PMID: 9242531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
Two hundred fifty-three patients with newly diagnosed acute promyelocytic leukemia (APL) were eligible to enter the multicentric GIMEMA-AIEOP "AIDA" trial during the period July 1993 to February 1996. As a mandatory prerequisite for eligibility, all patients had genetic evidence of the specific t(15;17) lesion in their leukemic cells confirmed by karyotyping or by reverse transcription-polymerase chain reaction (RT-PCR) of the PML/RAR alpha fusion gene (the latter available in 247 cases). Median age was 37.8 years (range, 2.2 to 73.9). Induction treatment consisted of oral all-trans retinoic acid (ATRA), 45 mg/m2/d until complete remission (CR), given with intravenous Idarubicin, 12 mg/m2/d on days 2, 4, 6, and 8. Three polychemotherapy cycles were given as consolidation. Hematologic and molecular response by RT-PCR was assessed after induction and after consolidation. At the time of analysis, 240 of the 253 eligible patients were evaluable for induction. Of these, 11 (5%) died of early complications and 229 (95%) achieved hematologic remission. No cases of resistant leukemia were observed. Of 139 cases studied by RT-PCR after induction, 84 (60.5%) were PCR-negative and 55 (39.5%) PCR-positive. One hundred sixty-two patients were evaluable by RT-PCR at the end of consolidation. Of these, 159 (98%) tested PCR-negative and 3 (2%), PCR-positive. After a median follow up of 12 months (range, 0 to 33), the estimated actuarial event-free survival for the whole series of 253 eligible patients was 83% +/- 2.6% and 79% +/- 3.2% at 1 and 2 years, respectively. This study indicates that the AIDA protocol is a well-tolerated regimen that induces molecular remission in almost all patients with PML/RAR alpha-positive APL. Preliminary survival data suggest that a remarkable cure rate can be obtained with this treatment.
Collapse
MESH Headings
- Adolescent
- Adult
- Aged
- Antibiotics, Antineoplastic/administration & dosage
- Antibiotics, Antineoplastic/adverse effects
- Antineoplastic Combined Chemotherapy Protocols/adverse effects
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Biomarkers, Tumor/analysis
- Bone Marrow/chemistry
- Bone Marrow/pathology
- Child
- Child, Preschool
- Chromosomes, Human, Pair 15/genetics
- Chromosomes, Human, Pair 15/ultrastructure
- Chromosomes, Human, Pair 17/genetics
- Chromosomes, Human, Pair 17/ultrastructure
- Disease-Free Survival
- Female
- Humans
- Idarubicin/administration & dosage
- Idarubicin/adverse effects
- Leukemia, Promyelocytic, Acute/drug therapy
- Leukemia, Promyelocytic, Acute/genetics
- Leukemia, Promyelocytic, Acute/mortality
- Leukemia, Promyelocytic, Acute/pathology
- Leukocytosis/chemically induced
- Male
- Middle Aged
- Neoplasm Proteins/analysis
- Neoplasm, Residual
- Oncogene Proteins, Fusion/analysis
- Polymerase Chain Reaction
- Prospective Studies
- Remission Induction
- Syndrome
- Translocation, Genetic
- Treatment Outcome
- Tretinoin/administration & dosage
- Tretinoin/adverse effects
Collapse
Affiliation(s)
- F Mandelli
- Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Giona F, Annino L, Rondelli R, Arcese W, Meloni G, Testi AM, Moleti ML, Amadori S, Resegotti L, Tabilio A, Ladogana S, Fioritoni G, Camera A, Liso V, Leoni P, Mandelli F. Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol. Br J Haematol 1997; 97:896-903. [PMID: 9217194 DOI: 10.1046/j.1365-2141.1997.1102926.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Sixty-one adults aged <55 years with acute lymphoblastic leukaemia (ALL) in first bone marrow relapse were enrolled in an Italian cooperative study (ALL R-87 protocol) from 12 GIMEMA Institutions. The treatment programme consisted of: (1) an induction phase with intermediate-dose cytarabine (IDARA-C 1 g/m2, 6 h daily infusion x 6 d) plus idarubicin (IDA; 5 mg/m2/d x 6 d) and prednisone (40 mg/m2/d x 21 d), (2) a consolidation phase followed by (3) bone marrow transplant (BMT). Median first complete remission (CR) duration was 8.5 months (range 1-54 months). 34/61 patients achieved CR (56%); 24 (39%) failed to respond and three (5%) died during induction. Most responders (24 patients) could not enter the BMT programme; 15 relapsed early (median time to relapse 2 months); nine were withdrawn due to toxicity and one died in CR of infection. Nine of the 34 CRs underwent BMT (five autologous and four allogeneic). Three of the four allotransplanted patients are alive in continuous CR at 22, 43 and 63 months; only one of the five who underwent an autologous BMT is alive in CR at 46 months. The estimated disease-free survival (DFS +/- SE) at 36 months was 0.16 +/- 0.08 for all responders. Univariate analysis showed that previous therapy was the only prognostic factor influencing DFS. The estimated probabilities of event-free survival (EFS +/- SE) and survival +/- SE at 37 months were 0.09 +/- 0.04 and 0.10 +/- 0.04, respectively. The EFS was significantly better in patients with a preceding CR > or = 24 months, compared to those with a shorter first remission. Our results confirm the tolerance and efficacy of IDARA-C plus IDA in inducing CR in poor-risk adult ALL. Even though the number of transplanted patients was small, allogeneic BMT seems to give a real opportunity of cure in this category of patients.
Collapse
Affiliation(s)
- F Giona
- Ematologia, Dipartimento di Biopatologia Umana, Università La Sapienza, Roma, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
D'Antonio D, Pizzigallo E, Lacone A, Violante B, Di Marzio A, Lombardo M, Fioritoni G, Staniscia T, Romano F. The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. J Antimicrob Chemother 1996; 38:839-47. [PMID: 8961053 DOI: 10.1093/jac/38.5.839] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
A single dose of 200 mg/day rufloxacin was investigated for preventing infection and for its impact on the commensal flora in a pilot study of 62 patients undergoing cytotoxic treatment for cancer. No infection caused by Gram-negative bacilli occurred among 54 assessable patients but prophylaxis was replaced by empirical treatment for fever in 19 cases and because of an adverse event, in a further three cases. The remaining 32 patients completed prophylaxis. The number of oral Branhamella spp., faecal Enterobacteriaceae and Bacteriodes spp. were significantly reduced whereas there was little effect of rufloxacin on the numbers of the other oral and faecal microflora. However, resistance to rufloxacin increased among both oral viridans streptococci, coagulase negative staphylococci and the faecal enterococci. These preliminary data suggest that selective oral antimicrobial prophylaxis for patients with cancer might be achieved with once-daily rufloxacin.
Collapse
Affiliation(s)
- D D'Antonio
- Dipartimento di Ematologia e della Trasfusione, Ospedale Civile di Pescara, Università G D'Annunzio, Chieti, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Calabrese G, Min T, Stuppia L, Powles R, Swansbury JG, Morizio E, Peila R, Donti E, Fioritoni G, Palka G. Complex chromosome translocations of standard t(8;21) and t(15;17) arise from a two-step mechanism as evidenced by fluorescence in situ hybridization analysis. Cancer Genet Cytogenet 1996; 91:40-5. [PMID: 8908165 DOI: 10.1016/s0165-4608(96)00096-9] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The authors report the results of cytogenetic and fluorescence in situ hybridization (FISH) analysis performed on complex chromosome translocations (CCTs) of t(8;21) and t(15;17) standard translocations associated with two M2 subtypes of acute myeloid leukemia (AML-M2) and four acute promyelocytic leukemia (APL), respectively. In one of two AML-M2 patients FISH analysis showed part of chromosome 21 on the der(8) and material from this chromosome on the der(21) and on chromosome 1 at band p32, suggesting that the t(8;21) occurred as the primary step. In the second AML-M2 patient. FISH displayed part of chromosome 21 on the der(8) and material from this chromosome on the der(21) but not on the third rearranged chromosome. Therefore, it is unclear whether chromosome 2 was rearranged secondary to the standard t(8;21). In four APL patients, FISH analysis showed material derived from chromosome 17 on the der(15). Moreover, in two patients with an i(17q) FISH disclosed material from chromosome 15 at the ends of both arms of the i(17q), suggesting that it occurred after the standard t(15;17). In the remaining two APL patients, FISH showed material from chromosome 15 on the der(17) and on chromosome 21 at band q22 in one case, and material of the p arm of chromosome 17 on chromosome 4 at band q11 in the other, demonstrating that in these two cases the first mutation also had been the t(15;17). Therefore, FISH analysis revealed that CCTs in five patients were secondary changes which occurred after standard t(8;21) and t(15;17), thus clarifying the hierarchy of the cytogenetic events, their role in the pathogenesis of the disease, and the associated clinic-hematologic findings.
Collapse
MESH Headings
- Adult
- Child, Preschool
- Chromosomes, Human, Pair 15/genetics
- Chromosomes, Human, Pair 17/genetics
- Chromosomes, Human, Pair 21/genetics
- Chromosomes, Human, Pair 8/genetics
- Female
- Humans
- In Situ Hybridization, Fluorescence
- Karyotyping
- Leukemia, Myeloid, Acute/genetics
- Leukemia, Promyelocytic, Acute/genetics
- Male
- Translocation, Genetic/genetics
Collapse
Affiliation(s)
- G Calabrese
- Istituto di Biologia e Genetica, Università di Chieti, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
D'Antonio D, Piccolomini R, Iacone A, Fioritoni G, Parruti G, Betti S, Quaglietta AM, Accorsi P, Dell'Isola M, Favalli C. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. J Antimicrob Chemother 1994; 33:837-44. [PMID: 8056702 DOI: 10.1093/jac/33.4.837] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
The efficacy of oral prophylaxis with ciprofloxacin, ofloxacin or pefloxacin was assessed in preventing bacterial infection in neutropenic patients with treatment being allocated randomly before beginning chemotherapy. Bacteraemia developed in six of 78 episodes (8%) treated with ciprofloxacin, in eight of 80 (10%) allocated to ofloxacin and in 12 of 77 (16%) when pefloxacin was given. However, there were no episodes involving Gram-negative bacilli among those given ciprofloxacin whereas three and seven episodes occurred in patients given ofloxacin or pefloxacin respectively (P = 0.013). With the exception of Pseudomonas aeruginosa, all potential pathogens isolated were resistant to all three fluoroquinolones. Faecal anaerobes were not affected by treatment with pefloxacin whereas their total numbers were reduced in 12 cases who had received ofloxacin and in nine cases who had been given ciprofloxacin (P = 0.002). Fourteen patients (18%) were colonized with pefloxacin resistant P. aeruginosa at the end of treatment with this agent compared with only two and five of those given ciprofloxacin or ofloxacin respectively. A similar trend was seen with other resistant Gram-negative bacilli colonizing 14%, 20% and 23% of patients for ciprofloxacin, ofloxacin and pefloxacin, respectively. Ciprofloxacin was therefore superior to the other two fluoroquinolones in preventing infections due to Gram-negative bacteria in this population of neutropenic patients.
Collapse
Affiliation(s)
- D D'Antonio
- Department of Haematology-Microbiology Laboratory, Pescara Civil Hospital, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
D'Antonio D, Piccolomini R, Fioritoni G, Iacone A, Betti S, Fazii P, Mazzoni A. Osteomyelitis and intervertebral discitis caused by Blastoschizomyces capitatus in a patient with acute leukemia. J Clin Microbiol 1994; 32:224-7. [PMID: 8126186 PMCID: PMC263003 DOI: 10.1128/jcm.32.1.224-227.1994] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
We describe the first known case of vertebral osteomyelitis and discitis caused by Blastoschizomyces capitatus in a leukemic patient and the results of therapy. We also reconfirm the microbiological characteristics which differentiate this species from other yeastlike pathogens.
Collapse
Affiliation(s)
- D D'Antonio
- Servizio di Microbiologia, Ospedale Civile S. Spirito, Pescara, Italy
| | | | | | | | | | | | | |
Collapse
|
26
|
Pierelli L, Iacone A, Quaglietta AM, Nicolucci A, Menichella G, Benedetti Panici P, D'Antonio D, De Laurenzi A, De Rosa L, Fioritoni G. Haemopoietic reconstitution after autologous blood stem cell transplantation in patients with malignancies: a multicentre retrospective study. Br J Haematol 1994; 86:70-5. [PMID: 7912099 DOI: 10.1111/j.1365-2141.1994.tb03254.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
A retrospective study was undertaken to evaluate the efficacy of autologous blood stem cell transplantation (ABSCT) in terms of haemopoietic reconstitution after ablative chemotherapy or chemo-radiotherapy. 55 patients with malignancies, observed in four Italian institutions from January 1987 to June 1991, were eligible for evaluation. This series included 19 non-Hodgkin's lymphoma, 11 multiple myeloma, nine ovarian cancer, seven Hodgkin's disease, seven non-lymphocytic leukaemia, one acute lymphoblastic leukaemia, one neuroblastoma. 522 PBSC collections were performed on 55 patients. Following ABSCT, the rate of engraftment was positively related to the dose of CFU-GM infused and negatively to the presence of bone marrow involvement at conditioning. 48 patients out of 55 transplanted (87%) had rapid, complete and sustained engraftment. Three patients (5%) died of transplant-related complications. Considering that 60% of the patients in this series were in partial remission or in progressive disease at the time of ABSCT, we conclude that ABSCT is a safe approach for the use of ablative conditioning therapy in patients with a wide scope of malignancies, provided that a large number of CFU-GM have been collected after mobilizing treatment.
Collapse
Affiliation(s)
- L Pierelli
- Servizio di Ematologia ed Emotransfusione, Universitá Cattolica del Sacro Cuore, Roma, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Iacone A, Pierelli L, Quaglietta AM, Nicolucci A, Menichella G, Di Bartolomeo P, De Laurenzi A, Fioritoni G, Indovina A, Leone G. Survival after PBSC transplantation and comparison of engraftment speed with autologous and allogeneic marrow transplantation: results of a multicenter study. Int J Artif Organs 1993; 16 Suppl 5:45-50. [PMID: 7912232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
We have analyzed the results of a multicenter study on peripheral blood stem cell transplantation (PBSCT) performed on 55 patients suffering from various neoplastic diseases. After myeloablative therapy, they received a median of 6.8 x 10(8)/kg MNC and 11.4 x 10(4)/kg CFU-GM harvested by a median of 9 apheresis after mobilization with chemotherapy alone. As of date, 34 of the 55 patients are alive and 28 of them are in continuous complete remission after a follow-up of 30 months. The probability of survival was related to the disease status at transplant, CR/PR vs. PD (p = 0.0001) and the bone marrow involvement, BM-vs. BM+ (P = 0.009). Furthermore, a comparative study on speed of engraftment and clinical management was conducted on the 55 PBSCT patients as well as on 41 autoBMT and 52 alloBMT patients. Days to reach WBC > 1.0 x 10(9)/L, PMN > 0.5 x 10(9)/L and PLT > 50 x 10(9)/L was 12/14/33 for PBSCT, 17/20/23 for ABMT and 15/16.5/18 for BMT, respectively. Days with fever > 38 degrees C, systemic antibiotic therapy and length of hospitalization was 3/12/36 for PBSCT, 5/18.5/42 for ABMT and 9/25/46 for BMT respectively.
Collapse
Affiliation(s)
- A Iacone
- Department of Hematology and Transfusion, Pescara Civic Hospital, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Pierelli L, Iacone A, Quaglietta AM, Nicolucci A, Menichella G, Benedetti Panici P, De Laurenzi A, De Rosa L, Fioritoni G, Indovina A. Autologous blood stem cell collection after chemotherapy in patients with sensitive and refractory malignancies: a multicenter retrospective study. Int J Artif Organs 1993; 16 Suppl 5:19-24. [PMID: 7912230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
A retrospective study was undertaken to assess the factors affecting the yield of peripheral blood stem cell (PBSC) collections after chemotherapy. Fifty-five patients with malignancies, observed in 4 Italian Institutions from January 1987 to June 1991 were eligible for evaluation. This series included 19 non-Hodgkin lymphoma, 11 multiple myeloma, 9 ovarian cancer, 7 Hodgkin disease, 7 acute non-lymphocytic leukemia, 1 acute lymphoblastic leukemia, 1 neuroblastoma. Five hundred and twenty two PBSC collections were performed on 55 patients after a median of 18 days after the start of chemotherapy. The yields of PBSC collections were related to the dose of cytoreductive chemotherapy exploited for PBSC mobilization and to the number of circulating white blood cells, colony forming unit granulocyte/macrophage (CFU-GM) and the percentage of monocytes at the time of collection. Forty-eight patients out of 55 transplanted (87%) had rapid, complete and sustained engraftment. Three patients (5%) died of transplant related complications.
Collapse
Affiliation(s)
- L Pierelli
- Department of Hematology, Sacro Cuore Catholic University, Roma, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Di Bartolomeo P, Olioso P, Papalinetti G, Bavaro P, Di Girolamo G, Angrilli F, Accorsi P, Quaglietta A, D'Antonio D, Piergallini A, Dell'isola M, Angelini A, Ciancarelli M, Fioritoni G, Iacone A, Torlontano G. The Role of Hemapheresis Technology in Allogeneic Bone Marrow Transplantation. Int J Artif Organs 1993. [DOI: 10.1177/039139889301605s01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
In this paper the impact of hemapheresis technology on 238 allogeneic bone marrow transplants performed in Pescara from 1982 through 1993 is described. Granulocyte transfusions were limited to patients with neutrophil level <0.2x109/L. An average of 4 units of packed red blood cells were required to maintain adequate hemoglobin levels. Patients with major ABO incompatibility showed an increased requirement of red blood cell support as compared to patients ABO-matched and ABO minor mismatched. For platelet support single-donor platelets collected on a blood-cell separator were given. A total of 1548 platelet transfusions were examined. The median number of platelet transfusions for each patient was 5. Platelet refractoriness occurred in 44% of patients. The hemorrhage related mortality was 0.9%.The advancement made in the field of hemapheresis technology, as well as the improved transplant technique, have contributed to increase the post-transplant survival from 17% in the early experience (1976-1982) to 88% in the recent years (1992-1993).
Collapse
Affiliation(s)
- P. Di Bartolomeo
- Department of Hematology and Bone Marrow Transplantation Unit, Pescara Civil Hospital, Pescara
| | - P. Olioso
- Department of Hematology and Bone Marrow Transplantation Unit, Pescara Civil Hospital, Pescara
| | - G. Papalinetti
- Department of Hematology and Bone Marrow Transplantation Unit, Pescara Civil Hospital, Pescara
| | - P. Bavaro
- Department of Hematology and Bone Marrow Transplantation Unit, Pescara Civil Hospital, Pescara
| | - G. Di Girolamo
- Department of Hematology and Bone Marrow Transplantation Unit, Pescara Civil Hospital, Pescara
| | - F. Angrilli
- Department of Hematology and Bone Marrow Transplantation Unit, Pescara Civil Hospital, Pescara
| | - P. Accorsi
- Department of Hematology and Blood Bank, Pescara Civil Hospital, Pescara
| | - A.M. Quaglietta
- Department of Hematology and Blood Bank, Pescara Civil Hospital, Pescara
| | - D. D'Antonio
- Department of Hematology and Blood Bank, Pescara Civil Hospital, Pescara
| | - A. Piergallini
- Department of Hematology and Blood Bank, Pescara Civil Hospital, Pescara
| | - M. Dell'isola
- Department of Hematology and Blood Bank, Pescara Civil Hospital, Pescara
| | - A. Angelini
- Chair of Hematology, University of Chieti, Chieti
| | - M. Ciancarelli
- Department of Hematology and Blood Bank, Pescara Civil Hospital, Pescara
| | - G. Fioritoni
- Department of Hematology and Bone Marrow Transplantation Unit, Pescara Civil Hospital, Pescara
| | - A. Iacone
- Department of Hematology and Blood Bank, Pescara Civil Hospital, Pescara
| | - G. Torlontano
- Chair of Hematology, University of Chieti, Chieti
- IRCCS, San Giovanni Rotondo, Foggia - Italy
| |
Collapse
|
30
|
Pierelli L, Iacone A, Quaglietta A, Nicolucci A, Menichella G, Panici PB, De Laurenzi A, De Rosa L, Fioritoni G, Indovina A, Leone G, Majolino I, Montuoro A, Scimé R. Autologous Blood Stem Cell Collection after Chemotherapy in Patients with Sensitive and Refractory Malignancies: A Multicenter Retrospective Study. Int J Artif Organs 1993. [DOI: 10.1177/039139889301605s04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
A retrospective study was undertaken to assess the factors affecting the yield of peripheral blood stem cell (PBSC) collections after chemotherapy. Fifty-five patients with malignancies, observed in 4 Italian Institutions from January 1987 to June 1991 were eligible for evaluation. This series included 19 non-Hodgkin lymphoma, 11 multiple myeloma, 9 ovarian cancer, 7 Hodgkin disease, 7 acute non-lymphocytic leukemia, 1 acute lymphoblastic leukemia, 1 neuroblastoma. Five hundred and twenty two PBSC collections were performed on 55 patients after a median of 18 days after the start of chemotherapy. The yields of PBSC collections were related to the dose of cytoreductive chemotherapy exploited for PBSC mobilization and to the number of circulating white blood cells, colony forming unit granulocyte/macrophage (CFU-GM) and the percentage of monocytes at the time of collection. Forty-eight patients out of 55 transplanted (87%) had rapid, complete and sustained engraftment. Three patients (5%) died of transplant related complications.
Collapse
Affiliation(s)
- L. Pierelli
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - A. Iacone
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | - A.M. Quaglietta
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | - A. Nicolucci
- Mario Negri Sud Institute, S. Maria Imbaro, Chieti
| | - G. Menichella
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - P. Benedetti Panici
- Department of Ostetricia and Gynecology, “Sacro Cuore” Catholic University, Roma
| | | | - L. De Rosa
- Division of Hematology, San Camillo Hospital, Roma
| | - G. Fioritoni
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | - A. Indovina
- Division of Hematology, “Cervello” Hospital, Palermo - Italy
| | - G. Leone
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - I. Majolino
- Division of Hematology, “Cervello” Hospital, Palermo - Italy
| | - A. Montuoro
- Division of Hematology, San Camillo Hospital, Roma
| | - R. Scimé
- Division of Hematology, “Cervello” Hospital, Palermo - Italy
| |
Collapse
|
31
|
D'Antonio D, Fioritoni G, Iacone A, Betti S, Fazii P, Dell'Isola M, Di Gianfilippo R, Di Silverio A, Ubezio S, Zeccara C. Hepatosplenic infection caused by Candida parapsilosis in patients with acute leukemia. Mycoses 1992; 35:311-3. [PMID: 1302805 DOI: 10.1111/j.1439-0507.1992.tb00884.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Candida parapsilosis is an exceptional agent in hepatosplenic candidosis. Here we report two cases of hepatosplenic infection caused by Candida parapsilosis in two patients with acute leukaemia. Open liver-spleen biopsy and previously minimal exposure to systemic antifungal drugs led to a cultural diagnosis in both patients. This report confirms the importance of an early diagnosis of these diseases in order to undertake appropriate therapeutic regimens.
Collapse
Affiliation(s)
- D D'Antonio
- Laboratorio di Microbiologia Clinica-Università degli Studi G. D'Annunzio, Chieti, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
D'Antonio D, Pizzigallo E, Iacone A, Dell'Isola M, Fioritoni G, Betti S, Piergallini A, Di Gianfilippo R, Olioso P, Torlontano G. Occurrence of bacteremia in hematologic patients. Eur J Epidemiol 1992; 8:687-92. [PMID: 1426168 DOI: 10.1007/bf00145385] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
In the present study we reviewed eighty-six episodes of bacteremia occurred in 60 neutropenic patients and thirty-one episodes occurred in 30 non-neutropenic patients. Twenty-four out of 60 neutropenic patients suffered from multiple episodes of bacteremia, while only one out of 30 non-neutropenic patients presented multiple episodes. In neutropenic patients, 29 episodes of bacteremia were polymicrobial, whereas only one non-neutropenic patient had polymicrobial bacteremia. Intravascular catheters were the most common source of bacteremia (23.2%) in neutropenic patients, as compared with infections of the genito-urinary tract (45.1%) among non-neutropenic patients. In both groups, aerobic gram-positive cocci were the microorganisms most frequently isolated (71.6%). Anaerobic microorganisms showed an higher incidence in polymicrobial episodes than in monomicrobial episodes x 2 = 5.39 p = 0.02 OR = 2.97 95% CI (1.2-7.7).
Collapse
Affiliation(s)
- D D'Antonio
- Cattedra di Ematologia, Università G. D'Annunzio, Chieti, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Di Bartolomeo P, Di Girolamo G, Olioso P, Angrilli F, Dragani A, Palka G, Guanciali-Franchi P, Ciancarelli M, Papalinetti G, Fioritoni G. Allogeneic bone marrow transplantation for Fanconi anemia. Bone Marrow Transplant 1992; 10:53-6. [PMID: 1515879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Five patients (age range 7-14 years) received allogeneic bone marrow transplantation (BMT) for Fanconi anemia (FA). All patients showed progressive pancytopenia associated with congenital malformations. Diagnosis was confirmed by studies of cellular hypersensitivity to the clastogenic effect of the DNA crosslinking agent diepoxybutane. The conditioning regimen consisted of low dose cyclophosphamide (5 mg/kg x 4) and fractionated total body irradiation (167 cGy x 3). For graft-versus-host disease prophylaxis one patient was given cyclosporin alone while the remaining four patients received a combination of cyclosporin and two doses of methotrexate. Marrow was given unmanipulated from HLA-identical siblings. All patients are alive 18-67 months after grafting with Karnofsky scores of 100% and normal hemopoiesis of donor origin. Modifications in transplant protocols such as those here described have resulted in a decreased risk of severe transplant-related complications. These results confirm that BMT is a curative therapy in FA patients and should be considered as a first choice treatment if an HLA-identical donor is available.
Collapse
|
34
|
D'Antonio D, Di Bartolomeo P, Iacone A, Olioso P, Di Girolamo G, Angrilli F, Papalinetti G, Fioritoni G, Betti S, Torlontano G. Meningitis due to penicillin-resistant Streptococcus pneumoniae in patients with chronic graft-versus-host disease. Bone Marrow Transplant 1992; 9:299-300. [PMID: 1600416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Two episodes of meningitis due to penicillin-resistant Streptococcus pneumoniae occurring in two patients with chronic graft-versus-host disease (GVHD) are reported. Both patients were treated with ceftazidime. The first patient died, unresponsive to therapy. The second patient showed clinical improvement, reverting to her baseline mental status. This report draws attention to the fact that in chronic GVHD patients: (1) bacterial prophylaxis does not ensure protection against encapsulated bacteria; (2) rapid microbiological investigation is recommended with any upper respiratory tract infections.
Collapse
Affiliation(s)
- D D'Antonio
- Divisione di Ematologia-Laboratorio di Microbiologia Clinica Ospedale, Pescara, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Abstract
This report describes our experience with various techniques for the freezing of platelet-rich plasma, removed from the final product after leukapheresis procedures performed on 14 hematological patients. A total of 194 platelet units were frozen for subsequent autologous transfusion, by the following four methods: (1) 6% dimethyl sulfoxide (DMSO); (2) a combination of 5% DMSO/6% hydroxyethyl starch; (3) 3% glycerol; (4) 5% glycerol/4% glucose. Each technique was evaluated by measuring the percentage of platelet recovery, malondialdehyde (MDA) production, and lactate dehydrogenase release. To investigate the safety and therapeutic effectiveness of the previously frozen platelets, in vivo comparison of four platelet freezing methods was made in 8 thrombocytopenic patients, using corrected platelet increment (CCI), determined at 24 h. Our in vitro results indicate that the cryopreservation with 6% DMSO, without controlled cooling rate, provides significantly (p less than 0.05) greater platelet recovery (75%) as compared to other systems. The decrease of MDA production and the increase in plasma lactate measured after the thawing process was less in the DMSO-frozen units than in the other platelet units. When platelets, cryopreserved by this method, were subsequently transfused into patients, a significantly better CCI (greater than 5,000/microliters) was obtained. In our series, 6 patients were entirely supported with frozen autologous platelets. It appears from this study that a better understanding of the physical and biochemical events occurring during the freezing process will improve platelet cryopreservation, allowing a more systematic use of frozen platelets in the support of thrombocytopenic patients.
Collapse
Affiliation(s)
- A Angelini
- Chair of Hematology, University of Chieti, Civil Hospital, Pescara, Italy
| | | | | | | | | | | |
Collapse
|
36
|
Mandelli F, Vegna ML, Avvisati G, Amadori S, Spadea A, Cacciola E, Cantore N, De Laurenzi A, De Rosa C, Fioritoni G. A randomized study of the efficacy of postconsolidation therapy in adult acute nonlymphocytic leukemia: a report of the Italian Cooperative Group GIMEMA. Ann Hematol 1992; 64:166-72. [PMID: 1581404 DOI: 10.1007/bf01696218] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
The Italian Co-operative Group GIMEMA conducted a randomized trial in adult acute nonlymphocytic leukemia (ANLL) to assess the role of postconsolidation treatment. Of 448 evaluable patients entered into the study, 305 (68%) achieved a complete remission after a standard induction with daunorubicin and cytosine arabinoside (3 + 7; 2 + 5). Those in remission after a consolidation therapy including 4 courses of daunorubicin, cytosine arabinoside, and 6-thioguanine (DAT) were allocated to one of three arms: no treatment, conventional maintenance, or intensive postconsolidation therapy. The median disease-free survival (DFS) was 13 months, and the median survival was 14 months, with 26% surviving at 6.5 years. There was no difference in survival and in disease-free survival among the three postconsolidation arms. In conclusion our study, as others, suggests that the critical period of ANLL treatment is within the first 5-6 months.
Collapse
Affiliation(s)
- F Mandelli
- Dipartimento di Biopathologia Umana, Università La Sapienza, Roma, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Palka G, Calabrese G, Fioritoni G, Stuppia L, Guanciali Franchi P, Marino M, Antonucci A, Spadano A, Torlontano G. Cytogenetic survey of 80 patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1992; 59:45-50. [PMID: 1555190 DOI: 10.1016/0165-4608(92)90156-3] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
The authors report a cytogenetic survey of 80 patients with acute nonlymphocytic leukemia. The prognostic value of chromosome aberrations has been evaluated with three methods. The first one showed that patients with NN or AN bone marrow cellularity have a significantly better prognosis than those with AA cellularity; the second method confirmed the relatively good prognosis for patients with t(8;21) and abnormal 16 and a poor one for those with rearrangements of chromosomes 5 and/or 7. The authors also noted, surprisingly, that patients with hyperdiploidy had a significantly poorer prognosis than those with hypodiploidy and especially pseudodiploidy. The third method showed that patients with very complex karyotypes and a worse outcome than those with simple changes. Finally, they discuss the prognostic value of unusual and/or undeciphered chromosome changes detected in 18 patients, with a mean survival of 9.6 months, showing that these changes have a negative prognostic significance.
Collapse
Affiliation(s)
- G Palka
- Istituti di Biologia e Genetica, Università di Chieti, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
38
|
D'Antonio D, Fioritoni G, Iacone A, Dell'Isola M, Natale D, D'Arcangelo L, Betti S, Spadano A, Recchia A, Mastrangelo C. Randomized comparison of ceftriaxone versus ceftriaxone plus amikacin for the empirical treatment of infections in patients with altered host defense: microbiological and clinical evaluation. Chemotherapy 1992; 38:420-7. [PMID: 1288967 DOI: 10.1159/000239037] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Two hundred and eighty-four febrile episodes in immunocompromised patients were treated with ceftriaxone alone or in combination with amikacin. In the ceftriaxone-treated group, 60 out of 143 febrile episodes were microbiologically documented, while in the group receiving the combination therapy, there were 32 out of 140 (p = 0.0007). Gram-positive microorganisms were more common than gram-negative ones, accounting for 59 of the 101 isolated bacteria. The ceftriaxone regimen appeared to have a response rate comparable to the combination regimen (73.91 vs. 78.88%). Superinfections occurred under both regimens.
Collapse
Affiliation(s)
- D D'Antonio
- Laboratorio di Microbiologia Clinica, Ospedale Civile, Pescara, Italia
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
D'Antonio D, Iacone A, Fioritoni G, Di Bartolomeo P, Torlontano G. Patterns of infection in 41 patients with idiosyncratic drug-induced agranulocytosis. Ann Hematol 1991; 63:84-8. [PMID: 1912036 DOI: 10.1007/bf01707278] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
We examined the patterns of infection in 41 consecutive patients with idiosyncratic drug-induced agranulocytosis observed during the past 15 years. All patients were nursed in reverse isolation and treated prophylactically with oral antimicrobials and antifungal compounds. Nine of 41 patients remained without fever and did not need any parenteral antibiotic treatment for full recovery. The other 32 patients developed fever during the period of agranulocytosis and were treated with empirical antimicrobial therapy. Febrile episodes were documented microbiologically in 16 patients (eight with and eight without bacteremia) and clinically in six patients. In the other ten cases the fever was of unexplained origin. The observed pattern of infection was in accordance with the type of infection as reported in cancer patients during the granulocytopenic phase induced by cytotoxic drugs. Ten of 32 febrile patients showed improvement after empirical antimicrobial therapy, whereas three patients died, two of them of a lower respiratory tract infection and one of a massive hemorrhage due to necrosis of the carotid artery. In ten patients the signs and symptoms of infection resolved only after adjustment of the initial empirical scheme. In nine patients the fever persisted even after additional empirical antifungal therapy but subsided after recovery of the granulocytopenia.
Collapse
Affiliation(s)
- D D'Antonio
- Cattedra di Ematologia, Universitá G. D'Annunzio, Chieti, Italy
| | | | | | | | | |
Collapse
|
40
|
D'Antonio D, Iacone A, Fioritoni G, Dell'Isola M, Mastropasqua L, Lobefalo L, De Nicola GC, Paolone V, Di Gregorio P, Recchia A. Patterns of cytomegalovirus retinitis in immunocompromised patients treated with 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl) guanine (ganciclovir). J Chemother 1991; 3:162-6. [PMID: 1655992 DOI: 10.1080/1120009x.1991.11739085] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Five immunocompromised patients, four with AIDS and one who had undergone bone marrow transplantation, showing ocular signs of cytomegalovirus retinitis, were treated with 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl) guanine (Ganciclovir), given intravenously at the dose of 5 mg/kg twice daily for a period ranging from 10 to 20 days. At the end of the treatment, in 4 of 5 patients, the ophthalmoscopic picture had improved, with reduced exudation and an arrest in the progression of retinal necrosis, the pattern clearly indicating a trend towards organization and scarring. Complete resolution of the retinitis without subsequent relapse was observed only in the bone marrow transplant patient, who recovered immunologically, whereas improvement of the eye involvement was only transient in the three AIDS patients.
Collapse
Affiliation(s)
- D D'Antonio
- Cattedre di Ematologia, Università degli Studi G. D'Annunzio, Chieti, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
D'Antonio D, Iacone A, Fioritoni G, Dragani A, Betti S, Quaglietta AM, Di Gianfilippo R, Accorsi P, Recchia A, Di Girolamo A. Detection of bacterial contamination in bone marrow graft. Haematologica 1991; 76 Suppl 1:44-5. [PMID: 1864553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
A rapid method of determining bacterial contamination was used in a series of fifty-five bone marrow harvests (20 allogeneic and 35 autologous transplantations). The microbiological culture assays executed on bone marrow samples soon after the harvest and before the manipulation, showed a positivity only in the autologous bone marrow group. Another positivity was revealed after the freezing process of bone marrows for autologous transplantation. Two samples in the bone marrow group submitted to purging were positive after treatment and freezing process. In this study, the increase of bacterial contamination frequency seemed to be related to extensive handlings, such as pharmacological in vitro purging and freezing procedures.
Collapse
Affiliation(s)
- D D'Antonio
- Cattedre di Ematologia Microbiologia Università G.D'Annunzio, Chieti, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Stuppia L, Palka G, Fioritoni G, Calabrese G, Guanciali Franchi P, D'Arcangelo L, Torlontano G. Karyotypic changes identified by HaeIII restriction endonuclease banding in a patient with M2 acute non-lymphoblastic leukemia. Genes Chromosomes Cancer 1990; 1:310-1. [PMID: 2278962 DOI: 10.1002/gcc.2870010408] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
A patient with acute non-lymphoblastic leukemia, FAB type M2, showed a complex karyotype involving chromosomes 1 and 11. The breakpoints could not be exactly identified by GTG and QFQ banding. A subsequent analysis with Alul and HaeIII restriction enzyme staining allowed the detection of a translocation of the heterochromatic region of chromosome 1 to 11q21.
Collapse
Affiliation(s)
- L Stuppia
- Institute of Biology and Genetics, University of Chieti, Italy
| | | | | | | | | | | | | |
Collapse
|
43
|
D'Antonio D, Iacone A, Fioritoni G, Angelini A, Dragani A, Betti S, Di Bartolomeo P, Di Bartolomeo G, Accorsi P, Quaglietta AM. Infection after autologous blood-derived stem cell transplantation. Haematologica 1990; 75 Suppl 1:83-6. [PMID: 1972135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Ten patients who underwent autologous blood-derived stem cell transplantation (APBSCT) were studied retrospectively to determine the frequency and outcome of transplant associated infections during the hemopoietic reconstitution. Six patients developed an infection after transplant. Severe bacterial infections were unfrequent and mostly caused by gram-positive cocci. In no case pneumonia was observed and this scarce morbility of infection could be the result of early engraftment. None of them died for infection. The frequency of infections in APBSCT patients appears lower than the one observed in autologous bone marrow transplant patients.
Collapse
Affiliation(s)
- D D'Antonio
- Divisione di Ematologia e Centro Trasfusionale, Ospedale Civile, Pescara, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Petti MC, Broccia G, Caronia F, Di Raimondo F, Fioritoni G, Ladogana S, Leone G, Liso V, Musso M, Neri A. Therapy of acute myelogenous leukemia in adults. Haematol Blood Transfus 1990; 33:249-53. [PMID: 2182417 DOI: 10.1007/978-3-642-74643-7_45] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- M C Petti
- Dept. of Hematology I, University, Rome, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Angelini A, Dragani A, Iacone A, D'Antonio D, Accorsi P, Quaglietta AM, Berardi A, Fioritoni G, Di Bartolomeo P, D'Emilio G. Human bone marrow processing using Cobe 2991 and CS 3000 blood cell separators for further ex vivo manipulation. Haematologica 1990; 75 Suppl 1:43-7. [PMID: 2351343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Several automated procedures are now available to enrich stem cells from large bone marrow (BM) volumes prior to ex vivo treatment or cryopreservation. This report details our experience using a ficoll-hypaque (F/H) gradient on Cobe 2991 cell washer and a CS 3000 continuous flow separator, on 90 BM processed for allogeneic and autologous transplantation. In the Cobe series, from 70 BM aspirates, 89 +/- 5% of the original mononuclear cells (MNC) was found in the light density fraction with a erythrocytes (RBC) and granulocytes (PMN) removal of 98 +/- 1 and 97 +/- 4.5%, respectively. Over 80% of the initial myeloid precursors (CFU-GM) were recovered in a small final volume. Twenty BM processing were performed with a CS 3000 separator using program "3" and granulo chamber. This technique yielded 86 +/- 9% of the initial MNC while 85 +/- 10% of RBC and 90 +/- 1.1% of PMN was removed. Over 75% of the original CFU-GM was recovered in the final product. Both techniques are effective to large-scale purification of progenitor cells and readily available as routine procedures for marrow processing.
Collapse
Affiliation(s)
- A Angelini
- Divisione di Ematologia e Centro Trasfusionale, Ospeda-le Civile, Pescara, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Fioritoni G, Iacone A, D'Antonio D, Dragani A, Quaglietta AM, Accorsi P, Angelini A, Spadano A, Natale D, Berardi A. Autologous blood stem cell transplantation as intensive consolidation therapy in hematological malignancies. Haematologica 1990; 75 Suppl 1:60-4. [PMID: 1972130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Ten consecutive patients (pts), suffering from hematological malignancies (5 NHL, 3 ANLL and 2 HD), received high doses of radio-chemotherapy and autologous peripheral blood stem cell (PBSC) transplantation. Seven of them were in 1st CR, two in 3rd CR and one in refractory status. The recruitment of PBSC was performed during the conventional non-intensive schedule of therapy. The median interval between the remission and the transplant was 6 months (3-15). The pts received a median of 0.96 x10(9) MNC/Kg b.w. and of 3.8 x10(4) CFU-GM/Kg b.w. Hemopoietic recovery occurred promptly and the median number of days to reach WBC greater than 1.0 x10(9)/L was 10 (7-15), PMN greater than 0.5 x10(9)/L was 12 (10-34), platelets greater than 50 x10(9)/L was 13 (10-41) and reticulocytes greater than 20 x10(9)/L was 12 (10-15). Three pts relapsed after 14, 12 and 6 months, respectively. Two of them achieved a further remission and one died. The remaining seven, are alive and disease-free with a follow-up of 11 months (range 2-27).
Collapse
Affiliation(s)
- G Fioritoni
- Divisione di Ematologia e Centro Trasfusionale, Ospedale Civile, Pescara, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Iacone A, Dragani A, Fioritoni G, Quaglietta A, D'Antonio D, Montuoro A, De Rosa L, Scimè R, Majolino I, Menichella G. Autologous blood stem cell transplantation in hematological malignancies. The Italian experience. Italian Cooperative Study Group. Bone Marrow Transplant 1990; 5 Suppl 1:46-7. [PMID: 1969311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
48
|
D'Antonio D, di Girolamo A, Iacone A, Fioritoni G, Angelini A, Dragani A, Betti S, Dell'Isola M, Piccolomini R. Evaluation of azlocillin-amikacin combination for empirical therapy of infection in febrile neutropenic patients. J Chemother 1989; 1:407-12. [PMID: 2693624 DOI: 10.1080/1120009x.1989.11738934] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
We have evaluated the azlocillin-amikacin combination, given at a daily dose of 200 mg/kg and 15 mg/kg respectively, in the treatment of 62 consecutive febrile granulocytopenic patients (less than 500 PMN/microliters) affected by hematological disease. The effectiveness of the treatment was assessed in 60 patients, 44 (73%) of whom responded within 96 hours from the beginning. 36 of the responders showed microbiological and clinical infections, 2 had clinically documented pneumonia and 6 a possible infection. No improvement was obtained in 16 patients; 7 of whom suffered from clinical and microbiological infection, 2 from pulmonary mycosis, 4 from possible infection and 3 from doubtful infection. Seven of these patients subsequently responded to a proven antibiotic treatment, while only one of the remaining responded to a second-line empirical antibiotic schedule. These results suggest that the combination of azlocillin-amikacin was able to overcome about two-thirds of the infections, representing an effective remedy for the empiric treatment of febrile neutropenic patients.
Collapse
Affiliation(s)
- D D'Antonio
- Facoltà di Medicina e Chirurgia, Università degli Studi G. D'Annunzio, Chieti, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Torlontano G, Di Girolamo G, Di Bartolomeo P, Angrilli F, Papalinetti G, Olioso P, Dragani A, Fioritoni G, Iacone A, D'Antonio D. Enhancement of BMT management in children and adults. Bone Marrow Transplant 1989; 4 Suppl 4:59-60. [PMID: 2516756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- G Torlontano
- Institute of Hematology, University of Chieti, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Torlontano G, Di Girolamo G, Di Bartolomeo P, Angrilli F, Dragani A, Fioritoni G, Iacone A, D'Antonio D, Pomarici S, Amoroso A. [The allograft in acute lymphoblastic leukemia]. Haematologica 1989; 74:433-42. [PMID: 2512227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
|